Clinical Trial Update: Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing clevidipine with urapidil for nontraumatic intracerebral hemorrhage was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nontraumatic Intracerebral Hemorrhage

Drugs mentioned

• CLEVIPREX (clevidipine)
• Urapidil (urapidil)

Snippet

Sponsor: University of Zurich | Conditions: Nontraumatic Intracerebral Hemorrhage, Multiple Localized | Phase 4 | Status: WITHDRAWN